Government’s RICO Case Against NECC is Unprecedented
This article was originally published in The Gold Sheet
Executive Summary
A 131-count indictment unsealed last month that includes murder and racketeering allegations against New England Compounding Center pharmacists for violations of the FD&C Act is unprecedented and signals that the federal government is using more aggressive legal tools in prosecuting individuals whose products harm or kill consumers.
You may also be interested in...
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”
EU GMP Annex I Is A Top Priority For EMA While Industry Has Lingering Concerns
Questions about contamination control strategy raised as European Medicines Agency makes EU GMP Annex I revision a top priority in its 2021 work plan.